University of Toronto Professor, Vaughn Betz is helping Ontario-based medical device manufacturer, Theralase Technologies improve the effectiveness of light-activated cancer treatment. According to Betz, the SOSCIP collaboration’s efforts focus on using advanced computation to rapidly simulate what's going to happen when light probes are placed in certain places of the patients’ body.
Transcript
Request a conversation
Sign up now
